The rate in our data was consistent with reported percentages of BRAF V600E in melanomas seen in The Cancer Genome Atlas (TCGA) and AACR Genomics Evidence Neoplasia Information Exchange (GENIE) databases (35% [n = 480] and 21% [n = 7915], respectively) [1,2]. This evidence concerns the gene BRAF and neoplasm.